CJC-1295 No DAC + Ipamorelin
This blend combines CJC-1295 without DAC, a modified GHRH(1–29) peptide, with Ipamorelin, a synthetic pentapeptide in the growth hormone secretagogue class.
Product Procurement
Research-use catalog items with clear ordering, product context, and documentation support.
CJC-1295 No DAC + Ipamorelin — 20mg
$69.99
Product estimate
- NET VIAL CONTENT
- 20mg
- CATEGORY
- Specialty Compounds
- SKU
- ALS-CJCIPA-20MG
In stock
Research Use Notice
For laboratory research use only. Not for human or animal use or consumption. Not for diagnostic, therapeutic, or veterinary use. Product documentation and certificates of analysis do not establish safety or suitability for these uses.
Product Intelligence
CJC-1295 No DAC + Ipamorelin Blend Profile
CJC-1295 No DAC and Ipamorelin research blend linking GHRH-analogue and growth hormone secretagogue research, with 20mg total vial content.
20mg Total Vial Content
Each vial contains 20mg combined total of CJC-1295 No DAC and Ipamorelin.
GHRH / Secretagogue Pathway Context
Component research provides two distinct experimental contexts: GHRH-fragment analogues are studied through sequence–activity relationships in pituitary-cell assays, while Ipamorelin has been characterized using cultured pituitary cells and receptor-antagonist experiments that distinguish secretagogue signaling from the GHRH pathway. These studies describe the individual components and related peptide classes. (Cervini et al., 1998; PMID 9513600; Raun et al., 1998; PMID 9849822.)
- Product TypePeptide blend
- ComponentsCJC-1295 No DAC; Ipamorelin
- Total Vial Content20mg
- IdentifierCJC-1295 No DAC: PubChem CID 56841945; Ipamorelin: PubChem CID 9831659
Documentation
Verification & Documentation
Documentation is handled by product and lot. Use Standards to search for a matching record; if none appears, contact support with the product name, SKU, and lot number.